JUBILANT CADISTA PHARMACEUTICALS INC.

Jubilant Cadista Pharmaceuticals Inc. specializes in the manufacturing of pharmaceutical preparations, with a demonstrated focus on supplying critical drug products to federal healthcare systems. The company’s technical expertise lies in the formulation, production, and quality-controlled manufacturing of injectables, oral solids, and hematological therapeutics, adhering to current Good Manufacturing Practices (cGMP) and FDA regulatory standards. Their work supports the reliable, scalable production of high-compliance pharmaceuticals used in clinical and institutional settings, particularly in specialty therapeutic areas such as hematology and chronic disease management. The company’s precision in batch consistency, sterile processing, and supply chain integrity distinguishes it as a trusted manufacturer for mission-critical drug procurement. The Department of Veterans Affairs is the sole federal agency with which Jubilant Cadista has been contracted, indicating a focused relationship centered on fulfilling VA’s pharmaceutical supply needs under the Federal Supply Schedule. This engagement suggests alignment with VA’s requirements for reliable, long-term access to essential medications, particularly those used in veteran-specific care pathways, including oncology, immunology, and hematologic conditions. The contractor’s primary industry focus is NAICS 325412—Pharmaceutical Preparation Manufacturing—which encompasses the end-to-end production of finished dosage forms from active pharmaceutical ingredients. This vertical specialization positions the company within the federal biopharmaceutical supply chain, serving agencies that require sterile, stable, and regulated drug products for direct patient administration. Jubilant Cadista Pharmaceuticals Inc. is a small business structured as a 2L entity, headquartered in Yardley, Pennsylvania. While the company currently holds no formal government certifications, its operational compliance with federal pharmaceutical standards and direct delivery to the VA underscores its credibility within the government healthcare market. The firm maintains a targeted, niche presence focused on quality-driven manufacturing rather than broad diversification.